Are dopamine receptors present on human lymphocytes?

Area of Science:

• Immunology
• Neuropharmacology

Background:

• Human lymphocytes are investigated for potential dopamine receptor expression.
• The radioligand [3H] spiperone is commonly used to study dopamine D2 receptors.

Purpose of the Study:

• To characterize the binding of [3H] spiperone to human lymphocytes.
• To determine if dopamine receptors are present on the surface of human lymphocytes.

Main Methods:

• Incubation of human lymphocytes with [3H] spiperone.
• Competition binding assays using various drugs, including dopamine-active agents and isomers of butaclamol.
• Cell fragmentation and lysis experiments.
• Investigation of binding under conditions affecting active transport (iodoacetate, ion replacement).

Main Results:

• [3H] spiperone binding to lymphocytes was not saturable and lacked stereoselectivity.
• No correlation was found between the dopaminergic activity of drugs and their ability to displace the ligand.
• Chloroquine, a non-dopaminergic drug, was a potent displacer.
• Cell fragmentation and lysis significantly reduced ligand binding.
• Binding was unaffected by metabolic inhibitors or ion substitution, indicating a passive process.

Conclusions:

• The observed association of [3H] spiperone with human lymphocytes is likely due to passive cellular uptake, not specific receptor binding.
• Evidence does not support the existence of dopamine receptors on the surface of human lymphocytes.
• Further research is needed to elucidate the mechanisms of passive ligand accumulation in lymphocytes.